Just like the challenges of 9/11 required the United States to rethink how we shared information the COVID virus will cause the same fundamental changes not only in healthcare but in the other industries that support health care, our logistics, and education.
It is also important to implement through the Platform a “break the glass” platform-centric approach to a federated online registry that can be shared among multiple agencies and governmental bodies. The online registry would log recovered COVID-19 patients who have likely developed immunity to the coronavirus, this would help the effort to speed up the return to normal life in the U.S. This is similar to the “immunization registries for children” currently in place in the U.S., “where all the vaccines you got as a baby and young child all the way up until you’re in high school are recorded online in an immunization registry.
It’s very important to use the BioDatAi Platform because it is already HIPAA-compliant compliant. Privacy is respected and data is segmented in the federated databases and for research, the data can be made available the identified.
The Registry shall collect and maintain such other COVID-19 data as may assist healthcare providers, researchers, and individuals in need of treatment for the virus, and shall make the data readily accessible. It will also be interoperable with all the major hospitals and Dr. EHRs, laboratory information management systems and will interface with all the applicable databases at agencies such as CDC and Health and Human Services.
This can also be used in the “surveillance and data collection system” which is part of the coronavirus relief bill passed by congress. The advantage of a Platform is the flexibility in its ability to be interoperable in such a diverse environment.